Literature DB >> 1931233

Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection.

B McRae1, J A Lange, M S Ascher, F de Wolf, H W Sheppard, J Goudsmit, J P Allain.   

Abstract

The immune response to the p24 core antigen of human immunodeficiency virus type 1 (HIV-1) was studied in serial samples collected prospectively from 52 homosexual males in two separate cohorts from Amsterdam and San Francisco. p24 antibody levels were quantified with an antigen sandwich immunoassay using p24 recombinant antigen as capture and probe. Titers and slopes of dilution curves reflecting antibody affinity were analyzed. Only 45 of 52 men developed a measurable primary immune response to p24. In 17 (33%) patients there was a low response with maximum antibody titer below 66, shallow (low affinity) dilution curve, and 10 of the 17 became HIV antigen positive over a 2 year period. In 24 (46%) of the 52 patients titers ranged from 100-4000, steeper dilution curves were noted, and none became HIV antigen positive. Four (8%) men developed a strong immune response with high titers (greater than 12,000) and high affinity type dilution curve. Over time, after the peak immune response, antibody titer declined in some individuals related in part to the formation of immune complexes between HIV-1 p24 antigen and antibody which were dissociable. In vitro, the addition of increasing amounts of purified p24 antigen corresponded to decreasing antibody titer and a shallower dilution curve suggesting a preferential consumption of high affinity antibodies for complex formation. The magnitude of immune response to HIV-1 p24 antigen varies widely in infected homosexual men. Both the intrinsic ability to mount an immune response and immune complex formation contribute to the measurable antibody level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1931233     DOI: 10.1089/aid.1991.7.637

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  8 in total

1.  Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.

Authors:  E L Delwart; H Pan; H W Sheppard; D Wolpert; A U Neumann; B Korber; J I Mullins
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

3.  Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity.

Authors:  Bernard Weber; Lutz Gürtler; Rigmor Thorstensson; Ulrike Michl; Annelies Mühlbacher; Philippe Bürgisser; Roberto Villaescusa; Adolfo Eiras; Christian Gabriel; Herbert Stekel; Srivilai Tanprasert; Sinenaart Oota; Maria-Jose Silvestre; Cristina Marques; Maria Ladeira; Holger Rabenau; Annemarie Berger; Urban Schmitt; Walter Melchior
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 4.  Use of virologic assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee.

Authors:  S Hammer; C Crumpacker; R D'Aquila; B Jackson; J Lathey; D Livnat; P Reichelderfer
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

5.  Rapid HIV Antigen-Antibody Assays and Detection of Acute HIV Infection in Sub-Saharan Africa.

Authors:  Adedotun A Adetunji; Moses O Adewumi; Obaro S Michael; Samuel A Fayemiwo; Adesola Ogunniyi; Babafemi O Taiwo
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

6.  Intrapatient sequence variation of the gag gene of human immunodeficiency virus type 1 plasma virions.

Authors:  F K Yoshimura; K Diem; G H Learn; S Riddell; L Corey
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.

Authors:  D Chargelegue; C M O'Toole; B T Colvin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

8.  Identifying HIV infection in South African women: How does a fourth generation HIV rapid test perform?

Authors:  Kapila Bhowan; Emma Kalk; Sonjiha Khan; Gayle Sherman
Journal:  Afr J Lab Med       Date:  2011-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.